JASON SEYMOUR: Open Payments
NPI 1366400962 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 50 payments from 9 companies in 2025. Trend: 2023 $390 · 2024 $1,089 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $418 |
| Janssen Biotech, Inc. | 11 | $233 |
| LEO Pharma Inc. | 13 | $203 |
| Regeneron Healthcare Solutions, Inc. | 6 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| ABBVIE INC. | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
| Botanix SB Inc | 1 | $19 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $15 |
Products named: DUPIXENT, TREMFYA, ADBRY, RINVOQ, TALTZ, SOFDRA.
Industry payments across GA — which companies pay providers there.
